MicroRNA‑448 modulates the progression of neuropathic pain by targeting sirtuin 1

Chu,Yunchao; Ge,Weipeng; Wang,Xin

doi:10.3892/etm.2019.8165

MicroRNA‑448 modulates the progression of neuropathic pain by targeting sirtuin 1

Authors:
- Yunchao Chu
- Weipeng Ge
- Xin Wang
View Affiliations

Affiliations: Department of Pain Treatment, Shengli Oilfield Central Hospital, Dongying, Shandong 257034, P.R. China, Department of Anesthesiology, Shengli Oilfield Central Hospital, Dongying, Shandong 257034, P.R. China
Published online on: November 4, 2019 https://doi.org/10.3892/etm.2019.8165
Pages: 4665-4672
Copyright: © Chu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

MicroRNAs (miRNAs) play crucial roles in the pathogenesis of neuropathic pain. The present study investigated the effects of miR‑448 on the progression of neuropathic pain in a rat model of chronic constriction injury (CCI) of the sciatic nerve. Reverse‑transcription quantitative polymerase chain reaction was conducted to detect the gene expression. The paw withdrawal threshold (PWT) and paw withdrawal latency (PWL) were used to assess the pain threshold. The protein expression levels of interleukin (IL)‑6, IL‑1β and tumor necrosis factor-α (TNF‑α) were detected by ELISA. The target of miR‑448 was predicted by TargetScan software. The Student's t‑test or one‑way ANOVA were used to identify statistical differences among groups. miR‑448 was persistently upregulated in CCI rats, and both mechanical allodynia and thermal hyperalgesia in CCI rats were decreased following miR‑448 downregulation. The expression levels of IL‑1β, IL‑6 and TNF‑α were significantly increased in CCI rats compared with controls, and these effects were reversed following treatment with a miR‑448 inhibitor. A luciferase reporter assay revealed that sirtuin 1 (SIRT1) was a target gene of miR‑448. SIRT1 was found to abrogate the effect of miR‑448 on neuropathic pain development. Collectively, the results of the present study revealed that miR‑448 promoted neuropathic pain in CCI rats by regulating neuroinflammation via SIRT1. Therefore, SIRT1 may be considered as a novel biomarker for neuropathic pain.

View Figures

View References

1	Zhao Y and Yang Z: Effect of Wnt signaling pathway on pathogenesis and intervention of neuropathic pain. Exp Ther Med. 16:3082–3088. 2018.PubMed/NCBI
2	Sommer C, Leinders M and Üçeyler N: Inflammation in the pathophysiology of neuropathic pain. Pain. 159:595–602. 2018. View Article : Google Scholar : PubMed/NCBI
3	Bouhassira D and Attal N: Emerging therapies for neuropathic pain: New molecules or new indications for old treatments? Pain. 159:576–582. 2018. View Article : Google Scholar : PubMed/NCBI
4	Lema MJ, Foley KM and Hausheer FH: Types and epidemiology of cancer-related neuropathic pain: The intersection of cancer pain and neuropathic pain. Oncologist. 15 (Suppl 2):S3–S8. 2010. View Article : Google Scholar
5	Jiang YR, Du JY, Wang DD and Yang X: miRNA-130a improves cardiac function by down-regulating TNF-α expression in a rat model of heart failure. Eur Rev Med Pharmacol Sci. 22:8454–8461. 2018.PubMed/NCBI
6	Mao Q, Chen C, Liang H, Zhong S, Cheng X and Li L: Astragaloside IV inhibits excessive mesangial cell proliferation and renal fibrosis caused by diabetic nephropathy via modulation of the TGF-β1/Smad/miR-192 signaling pathway. Exp Ther Med. 18:3053–3061. 2019.PubMed/NCBI
7	Meng Y, Shang F and Zhu Y: miR-124 participates in the proliferation and differentiation of brain glioma stem cells through regulating Nogo/NgR expression. Exp Ther Med. 18:2783–2788. 2019.PubMed/NCBI
8	Wang JR, Liu B, Zhou L and Huang YX: MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer. Cancer Biomark. 24:159–172. 2019. View Article : Google Scholar : PubMed/NCBI
9	Wang J, Chu Y and Xu M, Zhang X, Zhou Y and Xu M: miR-21 promotes cell migration and invasion of hepatocellular carcinoma by targeting KLF5. Oncol Lett. 17:2221–2227. 2019.PubMed/NCBI
10	Qiu T, Wang K, Li X and Jin J: miR-671-5p inhibits gastric cancer cell proliferation and promotes cell apoptosis by targeting URGCP. Exp Ther Med. 16:4753–4758. 2018.PubMed/NCBI
11	Zhang Y, Su Z, An LJ, Li L, Wei M, Ge DJ and Liu HL: miR-98 acts as an inhibitor in chronic constriction injury-induced neuropathic pain via downregulation of high-mobility group AT-hook 2. J Cell Biochem. 120:10363–10369. 2019. View Article : Google Scholar : PubMed/NCBI
12	Wen J, He T, Qi F and Chen H: MiR-206-3p alleviates chronic constriction injury-induced neuropathic pain through targeting HDAC4. Exp Anim. 68:213–220. 2019. View Article : Google Scholar : PubMed/NCBI
13	Bao Y, Wang S, Xie Y, Jin K, Bai Y and Shan S: MiR-28-5p relieves neuropathic pain by targeting Zeb1 in CCI rat models. J Cell Biochem. 119:8555–8563. 2018. View Article : Google Scholar : PubMed/NCBI
14	Lu Y, Jian MY, Ouyang YB and Han RQ: Changes in rat brain MicroRNA expression profiles following sevoflurane and propofol anesthesia. Chin Med J (Engl). 128:1510–1515. 2015. View Article : Google Scholar : PubMed/NCBI
15	Bennett GJ and Xie YK: A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:87–107. 1988. View Article : Google Scholar : PubMed/NCBI
16	Schmalbruch H: Fiber composition of the rat sciatic nerve. Anat Rec. 215:71–81. 1986. View Article : Google Scholar : PubMed/NCBI
17	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
18	Ni HD, Xu LS, Wang Y, Li H, An K, Liu M, Liu Q, Deng H, He Q, Huang B, et al: Astrocyte activation in the periaqueductal gray promotes descending facilitation to cancer-induced bone pain through the JNK MAPK signaling pathway. Mol Pain. 15:17448069198319092019. View Article : Google Scholar : PubMed/NCBI
19	Degu H, Wondimagegnehu A, Yifru YM and Belachew A: Is health related quality of life influenced by diabetic neuropathic pain among type II diabetes mellitus patients in Ethiopia? PLoS One. 14:e02114492019. View Article : Google Scholar : PubMed/NCBI
20	Kanda H, Liu S, Kanao M, Yi H, Iida T, Huang W, Kunisawa T, Lubarsky DA and Hao S: Gene therapy with HSV encoding p55TNFR gene for HIV neuropathic pain: An evidence-based mini-review. Transl Perioper Pain Med. 2:24–32. 2017.PubMed/NCBI
21	Tilley DM, Cedeño DL, Kelley CA, DeMaegd M, Benyamin R and Vallejo R: Changes in dorsal root ganglion gene expression in response to spinal cord stimulation. Reg Anesth Pain Med. 42:246–251. 2017. View Article : Google Scholar : PubMed/NCBI
22	Safieh-Garabedian B, Nomikos M and Saadé N: Targeting inflammatory components in neuropathic pain: The analgesic effect of thymulin related peptide. Neurosci Lett. 702:61–65. 2019. View Article : Google Scholar : PubMed/NCBI
23	Chen P, Li Y, Li L, Yu Q, Chao K, Zhou G, Qiu Y, Feng R, Huang S, He Y, et al: Circulating microRNA146b-5p is superior to C-reactive protein as a novel biomarker for monitoring inflammatory bowel disease. Aliment Pharmacol Ther. 49:733–743. 2019. View Article : Google Scholar : PubMed/NCBI
24	Jia QW, Chen ZH, Ding XQ, Liu JY, Ge PC, An FH, Li LH, Wang LS, Ma WZ, Yang ZJ and Jia EZ: Predictive effects of circulating miR-221, miR-130a and miR-155 for coronary heart disease: A multi-ethnic study in China. Cell Physiol Biochem. 42:808–823. 2017. View Article : Google Scholar : PubMed/NCBI
25	Su HY, Lin ZY, Peng WC, Guan F, Zhu GT, Mao BB, Dai B, Huang H and Hu ZQ: MiR-448 downregulates CTTN to inhibit cell proliferation and promote apoptosis in glioma. Eur Rev Med Pharmacol Sci. 22:3847–3854. 2018.PubMed/NCBI
26	Zhang R, Sui L, Hong X, Yang M and Li W: MiR-448 promotes vascular smooth muscle cell proliferation and migration in through directly targeting MEF2C. Environ Sci Pollut Res Int. 24:22294–22300. 2017. View Article : Google Scholar : PubMed/NCBI
27	Hong X, Xu Y, Qiu X, Zhu Y, Feng X, Ding Z, Zhang S, Zhong L, Zhuang Y, Su C, et al: MiR-448 promotes glycolytic metabolism of gastric cancer by downregulating KDM2B. Oncotarget. 7:22092–22102. 2016. View Article : Google Scholar : PubMed/NCBI
28	Wang Y, Pang QJ, Liu JT, Wu HH and Tao DY: Down-regulated miR-448 relieves spinal cord ischemia/reperfusion injury by up-regulating SIRT1. Braz J Med Biol Res. 51:e73192018. View Article : Google Scholar : PubMed/NCBI
29	An J, Cai T, Che H, Yu T, Cao Z, Liu X, Zhao F, Jing J, Shen X, Liu M, et al: The changes of miRNA expression in rat hippocampus following chronic lead exposure. Toxicol Lett. 229:158–166. 2014. View Article : Google Scholar : PubMed/NCBI
30	Myers RR, Campana WM and Shubayev VI: The role of neuroinflammation in neuropathic pain: Mechanisms and therapeutic targets. Drug Discov Today. 11:8–20. 2006. View Article : Google Scholar : PubMed/NCBI
31	Fei H, Shi M, Chen L, Wang Z and Suo L: MicroRNA-18 promotes apoptosis of islet β-cells via targeting NAV1. Exp Ther Med. 18:389–396. 2019.PubMed/NCBI
32	Li QY, Xu HY and Yang HJ: Effect of proinflammatory factors TNF-α,IL-1β, IL-6 on neuropathic pain. Zhongguo Zhong Yao Za Zhi. 42:3709–3712. 2017.(In Chinese). PubMed/NCBI
33	Li HL, Sun JJ, Ma H, Liu SJ, Li N, Guo SJ, Shi Y, Xu YY, Qi ZY, Wang YQ, et al: MicroRNA-23a inhibits endometrial cancer cell development by targeting SIX1. Oncol Lett. 18:3792–3802. 2019.PubMed/NCBI
34	Wang S, Li C, Yu Y and Qiao J: Decreased expression of microRNA-145 promotes the biological functions of fibroblasts in hypertrophic scar tissues by upregulating the expression of transcription factor SOX-9. Exp Ther Med. 18:3450–3460. 2019.PubMed/NCBI
35	Yang H, Wu D, Li H, Chen N and Shang Y: Downregulation of microRNA-448 inhibits IL-1β-induced cartilage degradation in human chondrocytes via upregulation of matrilin-3. Cell Mol Biol Lett. 23:72018. View Article : Google Scholar : PubMed/NCBI
36	Li B, Ge L, Li M, Wang L and Li Z: miR-448 suppresses proliferation and invasion by regulating IGF1R in colorectal cancer cells. Am J Transl Res. 8:3013–3022. 2016.PubMed/NCBI
37	Fujita Y and Yamashita T: Sirtuins in neuroendocrine regulation and neurological diseases. Front Neurosci. 12:7782018. View Article : Google Scholar : PubMed/NCBI
38	Zhao H, Chen S, Gao K, Zhou Z, Wang C, Shen Z, Guo Y, Li Z, Wan Z, Liu C and Mei X: Resveratrol protects against spinal cord injury by activating autophagy and inhibiting apoptosis mediated by the SIRT1/AMPK signaling pathway. Neuroscience. 348:241–251. 2017. View Article : Google Scholar : PubMed/NCBI
39	Zhang Z, Ding X, Zhou Z, Qiu Z, Shi N, Zhou S, Du L, Zhu X, Wu Y, Yin X and Zhou C: SIRT1 alleviates diabetic neuropathic pain by regulating synaptic plasticity of spinal dorsal horn neurons. Pain. 160:1082–1092. 2019. View Article : Google Scholar : PubMed/NCBI
40	Cui C, Li Y and Liu Y: Down-regulation of miR-377 suppresses high glucose and hypoxia-induced angiogenesis and inflammation in human retinal endothelial cells by direct up-regulation of target gene SIRT1. Hum Cell. 32:260–274. 2019. View Article : Google Scholar : PubMed/NCBI
41	Chang YC, Lin CW, Hsieh MC, Wu HJ, Wu WS, Wu WC and Kao YH: High mobility group B1 up-regulates angiogenic and fibrogenic factors in human retinal pigment epithelial ARPE-19 cells. Cell Signal. 40:248–257. 2017. View Article : Google Scholar : PubMed/NCBI